Cargando…

Development and validation of different indirect ELISAs for MERS-CoV serological testing

Detalles Bibliográficos
Autores principales:	Al-Amri, S., Al-subhi, T., Hassan, A., Azhar, E., Hashem, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128511/ http://dx.doi.org/10.1016/j.jiph.2018.10.115

Ejemplares similares

Development and validation of different indirect ELISAs for MERS-CoV serological testing
por: Hashem, Anwar M., et al.
Publicado: (2019)

Serological investigation of MERS-CoV in humans between 2011-2016, Jeddah, Saudi Arabia
por: Degnah, A., et al.
Publicado: (2019)

Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA
por: Al-amri, Sawsan S., et al.
Publicado: (2019)

Inclusion of MERS‐spike protein ELISA in algorithm to determine serologic evidence of MERS‐CoV infection
por: Trivedi, Suvang, et al.
Publicado: (2017)

Serological identification of MERS-CoV in camels of Wasit province, Iraq
por: AL-Taee, Hala S. R., et al.
Publicado: (2023)

Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests
por: Ko, J.-H., et al.
Publicado: (2017)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2020)

Evaluation of sixteen ELISA SARS-CoV-2 serological tests
por: Jacot, Damien, et al.
Publicado: (2021)

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
por: Degnah, Afnan A., et al.
Publicado: (2020)

COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
por: Barry, Mazin, et al.
Publicado: (2020)

Serologic Assessment of Possibility for MERS-CoV Infection in Equids
por: Meyer, Benjamin, et al.
Publicado: (2015)

A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein
por: Faizo, Arwa A., et al.
Publicado: (2021)

Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018
por: Tolah, A., et al.
Publicado: (2020)

Molecular aspects of MERS-CoV
por: Rabaan, Ali A., et al.
Publicado: (2017)

Development of an Indirect ELISA for Serological Diagnosis of Bovine herpesvirus 5
por: Dummer, Luana A., et al.
Publicado: (2016)

Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats
por: Bold, Dashzeveg, et al.
Publicado: (2022)

Knowledge and practices of primary health care physicians regarding updated guidelines of MERS-CoV infection in Abha city
por: Al-Amri, Saad, et al.
Publicado: (2019)

Serological Cross-Reaction between Six Thiadiazine by Indirect ELISA Test and Their Antimicrobial Activity
por: Ortiz, Mishell, et al.
Publicado: (2023)

Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama
por: de la Guardia, Carolina, et al.
Publicado: (2021)

Serological evidence of MERS-CoV and HKU8-related CoV co-infection in Kenyan camels
por: Zhang, Wei, et al.
Publicado: (2019)

MERS-CoV diagnosis: An update
por: Al Johani, Sameera, et al.
Publicado: (2016)

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016)

MERS-CoV
por: Müller, Marcel A
Publicado: (2014)

Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
por: Luo, Ji, et al.
Publicado: (2022)

Drivers for MERS-CoV emergence in Qatar
por: Farag, E., et al.
Publicado: (2016)

Drivers of MERS-CoV Emergence in Qatar
por: Farag, Elmoubasher, et al.
Publicado: (2018)

Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)

Risk factors for serological evidence of MERS-CoV in camels, Kenya, 2016–2017()
por: Sitawa, Rinah, et al.
Publicado: (2020)

Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies
por: Nguyen, Nguyen N., et al.
Publicado: (2020)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
por: Al-Salihi, Karima A., et al.
Publicado: (2021)

NeoCoV Is Closer to MERS-CoV than SARS-CoV
por: Hassan, Mohamed M, et al.
Publicado: (2020)

Role of rapid antibody and ELISA tests in the evaluation of serological response in patients with SARS-CoV-2 PCR positivity
por: Cosgun, Yasemin, et al.
Publicado: (2021)

Emerging respiratory viral infections: MERS-CoV and influenza
por: Al-Tawfiq, Jaffar A, et al.
Publicado: (2014)

Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia
por: Faccini-Martínez, Álvaro A., et al.
Publicado: (2020)

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19
por: Phan, Isabelle Q., et al.
Publicado: (2021)

Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays
por: Michel, Moïse, et al.
Publicado: (2020)

Travel implications of emerging coronaviruses: SARS and MERS-CoV
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2014)

Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012–2015
por: Saqib, Muhammad, et al.
Publicado: (2017)

Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018
por: Tolah, Ahmed M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lm8d6lfk4mkliu9gtl5dagbh2i